Leading the $4 million bridge financing were The Aurora Funds, and S-Group Direct Investments, along with participation from other existing investors Innovation Ventures and several individuals.
Ray Swanson, president and CEO of Centice, said: “We are very pleased to close on this round of new financing as these funds secure our ability to commercialize our Pass Rx product in 2009.”